Characterization of Adeno Associated Virus (AAV) mediated immune responses

AAV vectors are used clinically to treat a number of rare inherited retina diseases, but also carry the risk of eliciting sight threatening ocular inflammation.  Establishing how AAV-mediated immunogenicity in the retina triggers acute and persistent inflammation is critical to developing approaches to avoid this sight threatening complication of treatment.